$INNV PR $0.253
mutiple support 'bottom'
descending
$INNV PR $0.253
mutiple support 'bottom'
descending triangle
Rentry last week
$0.2549
Flag support
multi-bagger corrected
OTC
100% Sell
Barchart
Might be 1st time I've recommended a 100% Sell
Last ten trades
Website
12/1/16
Innovus Pharma Launches its Clinically Proven UriVarx™ Product
for Bladder Health Through its Beyond Human® Sales and Marketing
Platform in the United States
11/29/16
Signs $2 Million a Year Exclusive License and Distribution Agreement
with J&H Co. LTD for Zestra® for Female Sexual Arousal in South Korea
Agreement Currently Expected to Add $20 million in Revenues Over the Life of the Agreement
Nov 21, 2016 Innovus Pharma Launches Zestra® Multi-Dose Form for Female Sexual Arousal in the U.S. Press Release
Nov 18, 2016 Innovus Pharma (INNV) Continues to Execute with Record Q3 '16 Revenue -- SECFilings.com Press Release
Nov 10, 2016 Innovus Pharma Reports Record Quarterly Revenues for the Third Quarter of 2016, Increasing 947% to $1.9 Million, and Record Nine Months Ended September 2016 Revenues, Increasing 463% to $3.1 Million Press Release
Nov 8, 2016 Innovus Pharma Signs Exclusive License and Distribution Agreement with Elis Pharmaceuticals for Zestra® in Lebanon Press Release
Nov 7, 2016 Innovus Pharmaceuticals to Release Third Quarter 2016 Financial Results and Provide Corporate Update on Thursday, November 10, 2016 Press Release
10-Q 11/15/16
O/S 106,080,636
Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the commercialization, licensing, and development of non-prescription medicine and consumer care products in the United States. Its products include Zestra, a non-medicated patented consumer care product to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph-compliant benzocaine-based topical gel for treating premature ejaculation; Sensum+, a non-medicated consumer care cream that enhances penile sensitivity; Zestra Glide, a high viscosity and low osmolality water-based lubricant; Vesele, a proprietary oral dietary supplement to enhance nitric oxide beneficial clinical effects on sexual functions and brain health; and Androferti to support overall male reproductive health and sperm quality. The companys pipeline products includes FlutiCare, an over the counter drug for Rhinitis; Urocis for urinary tract infection; and AndroVit, a proprietary supplement to support overall prostate and male sexual health. The company markets and sells its products through commercial partners to primary care physicians, urologists, gynecologists, and therapists; and directly to consumers through online channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. is headquartered in San Diego, California.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Top 5 Most Recently Viewed Articles
Bitcoin's Potential Surge Towards $100,000 Crypto analyst Trader Mayne has recently suggested that Bitcoin could be preparing for one final push toward the impressive milestone of $100,000. He notes, however, that the overall market cycle resembles a prolonged five-year super cycle, which may culminate in a significant downturn in the near future. Current Market...
Continue Reading
Geisinger Appoints Jason W. Mitchell, M.D. as CMO In a notable leadership transition, Geisinger has officially announced the appointment of Jason W. Mitchell, M.D. as its executive vice president and chief medical officer. This decision comes after an exhaustive search aimed at finding a leader with the vision and expertise to guide the organization into its next chapter....
Continue Reading
Insights Ahead of Euroseas's Earnings Report Euroseas (NASDAQ:ESEA) is gearing up to unveil its latest quarterly earnings, a moment that investors eagerly anticipate. This report holds substantial importance, as it can influence both investor sentiment and stock performance significantly. What Analysts Are Predicting Leading up to the earnings announcement, analysts...
Continue Reading
Atlantic Council and Antenna Group Unite for AEGGIS The Atlantic Council and Antenna Group have unveiled an exciting initiative known as the Alliance for Europe–Gulf Geopolitics & Investments Summit (AEGGIS). This summit is poised to play a pivotal role in strengthening the economic connections between European and Gulf nations. A Platform for Engagement and Dialogue...
Continue Reading
China Pharma's $5 Million Secured: A Strategic Move? Tough out there in the pharma jungle, isn't it? China Pharma Holdings, Inc. (NYSE American: CPHI) just wrapped up a neat $5 million direct offering. With each of their 2.5 million shares going for two bucks a pop, they're setting sails in a tumultuous sea. Now, why does this matter? Well, cash moshes in the pharma pit...
Continue Reading